Inogen, Inc. (INGN)

In the past six months, Inogen's stock has experienced fluctuations. As of January 26, 2026, the company's market capitalization was $163.17 million, reflecting a decrease of -4.6% over the past 30 days and -10.57% over the last 12 months. Key events include the announcement of Third Quarter 2025 Financial Results with $92.4 million in revenue and positive adjusted EBITDA, the launch of Aurora CPAP Masks in the United States, and preliminary Q4 2025 revenue results estimating $82 million in revenue and positive Adjusted EBITDA for the full year 2025, with a shift in the timing of some large customer orders into the first half of 2026.

Specific details regarding the seasonality of demand for Inogen's products and services are not explicitly elaborated upon. However, Q4 2025 preliminary results noted a shift in the timing of a few large customer orders into the first half of 2026, which could suggest some variability in demand patterns.

Inogen, Inc. is a medical technology company focused on developing, manufacturing, and marketing respiratory products for homecare, particularly portable oxygen concentrators (POCs) for patients with chronic respiratory conditions. Their major products include the Inogen One and Rove systems, which are lightweight alternatives to traditional oxygen sources. Inogen also offers Inogen Connect, a wireless connectivity platform, Simeox, an airway clearance device, and Aurora CPAP Masks for obstructive sleep apnea.

Inogen generates most of its revenue in the United States. The company distributes its products through home medical equipment providers and distributors across 59 international countries, as well as through a direct sales force in the U.S.

Inogen's brand reputation is built on improving lives through innovative respiratory care solutions. The company emphasizes business sustainability, core values, and a code of ethics, as well as diversity, equity, and inclusion. Inogen highlights the impact of over one million systems sold or rented worldwide. There have been no specific widely reported negative events that have significantly impacted Inogen's brand reputation in the past year. The company has focused on expanding its product portfolio with launches like the Voxi 5 stationary oxygen concentrator and Aurora Masks.

Inogen, Inc. has a significant institutional ownership base. As of the fourth quarter of 2025, 302 institutions held shares of Inogen Inc., with a combined market value of approximately $19.77 million, accounting for 72.81% of the total shares. Institutional investors hold 64.56% of the shares, while individual insiders hold 1.7% and the general public holds 16.3%. Major institutional owners include BlackRock, Inc., Vanguard Group Inc., and Acadian Asset Management Llc.